NewLink (NLNK), Intrexon (XON), OraSure (OSUR) Highlighted on Zika - Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Canaccord Genuity Reiterates Buy as OraSure Technologies (OSUR) Reports 4th Consecutive Quarter of Profit
February 4, 2016 9:59 AM ESTCanaccord Genuity reiterated a Buy rating and $8 price target on OraSure Technologies (NASDAQ: OSUR) following the company's 4Q earnings report. OSUR posted revenue of $32.4M, handily beating the Street's $29.8M estimate, as strength in the molecular collections systems segment and HCV sales... More
Zika Stock Intrexon (XON) Gains 5% Early
February 3, 2016 7:51 AM ESTZika stock Intrexon (NYSE: XON) is seeing early upside. Shares are up 5%.
NewLink Genetics (NLNK) Plans to Develop New Treatment Options for Zika Virus
February 2, 2016 8:59 AM ESTNewLink Genetics Corporation (NASDAQ: NLNK) today announced the company initiated a project... More
